Comparison of effectiveness of neuromuscular electrical stimulation and proprioception neuromuscular facilitation on EMG and balance in knee osteoarthritis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017011226443N3

Enrollment

Registered

2017-05-01

Start date

2017-02-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis. Other primary gonarthrosis

Interventions

Intervention 1: Second interventional group: Routine physical therapy treatment with quadriceps and hamstring strengthening by PNF pattern. Intervention 2: First interventional group: Routine physical

Rehabilitation

Second interventional group: Routine physical therapy treatment with quadriceps and hamstring strengthening by PNF pattern

First interventional group: Routine physical therapy treatment with quadriceps strengthening by PNF pattern and hamstring inhibition by ice

Third interventional group: Routine physical therapy with quadriceps and hamstring strengthening by PNF pattern and NMES

Control group: Routine physical therapy

Eligibility

Sex/Gender

All

Age

35 Years to 54 Years

Inclusion criteria

Inclusion criteria: Main inclusion ctiteria: Confirmation of knee osteoarthritis diagnosis by an specialist; WOMAC score 25 at least; VAS 4 at least; age between 35 it 54 Main exclusion criteria: History of knee fracture, tendon, meniscus and ligament tearing; rheumatoid arthritis; hip or ankle musculoskeletal disorders; central or peripheral neuropathy; history of physical therapy in last month; corticosteroid injection in last month; unconscious patients; neoplasy disorders, deep vain thrombosis, neurological dysfunction; sever obesity; pace maker

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Electeromyographic activity. Timepoint: before and after intervention and 1 month later. Method of measurement: EMG.	—

Secondary

Measure	Time frame
Pain. Timepoint: before and after intervention and 1 month later. Method of measurement: VAS.;Balance. Timepoint: before and after intervention and 1 month later. Method of measurement: biodex balance system.;Function. Timepoint: before and after intervention and 1 month later. Method of measurement: WOMAC questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBahareh Khodadadi Bohlouli

Zahedan University of Medical Science

bahereh_khodadadi@yahoo.com+98 54 3329 5836

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026